This company listing is no longer active
10B Stock Overview
Develops and sells wearable muscle strengthening systems worldwide. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Bioservo Technologies AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €0.05 |
| 52 Week High | €0.067 |
| 52 Week Low | €0.05 |
| Beta | 0.78 |
| 1 Month Change | 0% |
| 3 Month Change | 0% |
| 1 Year Change | -25.37% |
| 3 Year Change | -96.32% |
| 5 Year Change | -96.47% |
| Change since IPO | -97.14% |
Recent News & Updates
Recent updates
Shareholder Returns
| 10B | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | 0% | 1.5% | 2.6% |
| 1Y | -25.4% | -6.0% | 13.4% |
Return vs Industry: 10B underperformed the German Medical Equipment industry which returned 0.3% over the past year.
Return vs Market: 10B underperformed the German Market which returned 4.2% over the past year.
Price Volatility
| 10B volatility | |
|---|---|
| 10B Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 6.6% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 11.5% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 10B has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine 10B's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2003 | 20 | Petter Backgren | www.bioservo.com |
Bioservo Technologies AB (publ) develops and sells wearable muscle strengthening systems worldwide. The company offers Ironhand, a robotic grip that strengthens gloves; and Carbonhand, a revolutionary assistive device for people with impaired hand function. Its products have applications in foundry, logistics, warehousing, and construction sectors, as well as used in pre-assembly and assembly tasks.
Bioservo Technologies AB (publ) Fundamentals Summary
| 10B fundamental statistics | |
|---|---|
| Market cap | €4.27m |
| Earnings (TTM) | -€4.17m |
| Revenue (TTM) | €1.05m |
4.0x
P/S Ratio-1.0x
P/E RatioIs 10B overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 10B income statement (TTM) | |
|---|---|
| Revenue | SEK 11.86m |
| Cost of Revenue | SEK 10.28m |
| Gross Profit | SEK 1.58m |
| Other Expenses | SEK 48.51m |
| Earnings | -SEK 46.93m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.55 |
| Gross Margin | 13.30% |
| Net Profit Margin | -395.68% |
| Debt/Equity Ratio | 0% |
How did 10B perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/06/25 22:50 |
| End of Day Share Price | 2024/04/29 00:00 |
| Earnings | 2023/09/30 |
| Annual Earnings | 2022/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Bioservo Technologies AB (publ) is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Mats Hyttinge | Carlsquare AB |
| Mats Hyttinge | Redeye |